Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels

BACKGROUND: In chronic hepatitis B virus (HBV) patients, fluctuations in HBV DNA serve as a “gray area” and impede the accurate identification of inactive carriers. We aimed to assess if such fluctuations impact the presence of significant hepatic fibrosis (Metavir F2-4) in chronic HBV patients. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanai, Faisal M., Alhouthali, Ahmad H., Alghamdi, Hamdan S., Badriq, Feras, Sanai, Eisa A., Mujalled, Mohammed K., Khayyat, Waleed, Attar, Motaz S., Bagadeem, Basil S., Meer, Alaa M., Alshumrani, Waleed, Albeladi, Khalid, AlTraif, Ibrahim, Alqahtani, Saleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752532/
https://www.ncbi.nlm.nih.gov/pubmed/35488588
http://dx.doi.org/10.4103/sjg.sjg_48_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752532/
https://www.ncbi.nlm.nih.gov/pubmed/35488588
http://dx.doi.org/10.4103/sjg.sjg_48_22

Ejemplares similares